Compare Honeywell International Inc (HON) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Honeywell International IncTrade

Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Honeywell International Inc vs Zimmer Biomet Holdings Inc — how do they compare? Honeywell International Inc trades at $230.5 (market cap $72.93B), while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Honeywell International Inc is far larger — about 3.9× Zimmer Biomet Holdings Inc's market cap, and Honeywell International Inc pays the higher dividend (1.22%). Which is the better fit depends on your goals.

	HON	ZBH
Market Cap	$72.93B	$18.55B
Sector	Industrials	Health
52-Week High	$248.79	$107.71
52-Week Low	$188.14	$79.58
Enterprise Value	$97.73B	$25.61B
Dividend Yield	1.22%	0.99%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HON

Honeywell raises guidance, targets 4-6% growth and strong cash flow through 2029Seeking Alpha · 20 hours agoBullish Honeywell shares drop 4.7% after weak aerospace spin-off results and cautious growth outlook.24/7 Wall Street · 21 hours agoBearish Honeywell Aerospace shares plunge 20% post-spin-off, dragging down Honeywell International's outlook.Alex Lavoie · 2 days agoBearish View details →

ZBH

View details →

About Honeywell International Inc

Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.